CytoDyn Inc. (CYDY)
OTCMKTS
· Delayed Price · Currency is USD
0.2000
-0.0040 (-1.96%)
Apr 17, 2025, 4:00 PM EDT
CytoDyn Income Statement
Financials in millions USD. Fiscal year is June - May.
Millions USD. Fiscal year is Jun - May.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 28, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 | May '20 May 31, 2020 | 2015 - 2019 |
| Revenue | - | - | - | 0.27 | - | - | Upgrade
|
| Cost of Revenue | - | - | 20.63 | 73.54 | 5.03 | - | Upgrade
|
| Gross Profit | - | - | -20.63 | -73.28 | -5.03 | - | Upgrade
|
| Selling, General & Admin | 8.44 | 10.79 | 17.14 | 44.3 | 34.32 | 19.97 | Upgrade
|
| Research & Development | -16.55 | 7.24 | 2.63 | 27.04 | 53.4 | 52.64 | Upgrade
|
| Operating Expenses | -8.09 | 18.06 | 19.94 | 72.13 | 89.52 | 74.65 | Upgrade
|
| Operating Income | 8.09 | -18.06 | -40.58 | -145.4 | -94.55 | -74.65 | Upgrade
|
| Interest Expense | -4.8 | -8.67 | -15.51 | -24.18 | -22.11 | -33.25 | Upgrade
|
| Interest & Investment Income | 0.44 | - | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -2.03 | -3.06 | -18.43 | - | - | -9.54 | Upgrade
|
| EBT Excluding Unusual Items | 1.71 | -29.79 | -74.51 | -169.59 | -116.66 | -117.44 | Upgrade
|
| Asset Writedown | - | - | - | - | -10.05 | - | Upgrade
|
| Legal Settlements | - | - | - | -3.85 | -10.63 | -22.5 | Upgrade
|
| Other Unusual Items | -8.79 | -20.05 | -5.31 | -37.38 | -39.13 | - | Upgrade
|
| Pretax Income | -7.09 | -49.84 | -79.82 | -210.82 | -176.47 | -139.94 | Upgrade
|
| Net Income | -7.09 | -49.84 | -79.82 | -210.82 | -176.47 | -139.94 | Upgrade
|
| Preferred Dividends & Other Adjustments | 1.48 | 1.48 | 6.91 | 1.63 | 1.69 | 0.71 | Upgrade
|
| Net Income to Common | -8.57 | -51.32 | -86.74 | -212.45 | -178.15 | -140.64 | Upgrade
|
| Shares Outstanding (Basic) | 1,149 | 970 | 837 | 677 | 588 | 421 | Upgrade
|
| Shares Outstanding (Diluted) | 1,149 | 970 | 837 | 677 | 588 | 421 | Upgrade
|
| Shares Change (YoY) | 21.70% | 15.90% | 23.58% | 15.20% | 39.54% | 54.78% | Upgrade
|
| EPS (Basic) | -0.01 | -0.05 | -0.10 | -0.31 | -0.30 | -0.33 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.05 | -0.10 | -0.31 | -0.30 | -0.33 | Upgrade
|
| Free Cash Flow | -4.75 | -10.98 | -25.11 | -77.72 | -117.7 | -68.85 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.03 | -0.12 | -0.20 | -0.16 | Upgrade
|
| Operating Margin | - | - | - | -54663.16% | - | - | Upgrade
|
| Profit Margin | - | - | - | -79867.67% | - | - | Upgrade
|
| Free Cash Flow Margin | - | - | - | -29219.17% | - | - | Upgrade
|
| EBITDA | 8.11 | -18.03 | -40.4 | -144.62 | -92.75 | -72.61 | Upgrade
|
| D&A For EBITDA | 0.02 | 0.03 | 0.18 | 0.78 | 1.8 | 2.03 | Upgrade
|
| EBIT | 8.09 | -18.06 | -40.58 | -145.4 | -94.55 | -74.65 | Upgrade
|
Updated Jan 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.